Global Saliva Collection and Diagnostics Market Size Study, By Site of Collection (Parotid Gland Collection, Submandibular/Sublingual Gland Collection), By Application (Disease Diagnostics, Forensic Applications, Research), By End-Use (Diagnostic Laborato

Global Saliva Collection and Diagnostics Market Size Study, By Site of Collection (Parotid Gland Collection, Submandibular/Sublingual Gland Collection), By Application (Disease Diagnostics, Forensic Applications, Research), By End-Use (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies), and Regional Forecasts, 2022–2032

The Global Saliva Collection and Diagnostics Market is poised for significant growth, with an estimated valuation of USD 0.78 Billion in 2023, projected to reach USD 1.18 Billion by 2032, growing at a CAGR of 4.7% during the forecast period. This surge is attributed to rising advancements in non-invasive diagnostic technologies, growing awareness about saliva-based testing, and innovations in sample collection devices.

The COVID-19 pandemic acted as a key accelerator, highlighting saliva's potential as a viable sample type for diagnostic applications, including infectious disease testing. The non-invasive nature of saliva collection methods, coupled with innovations like the SpeciMAX Stabilized Saliva Collection Kit, has further propelled market adoption. Moreover, the expansion of saliva-based diagnostics beyond COVID-19 into areas such as hormonal monitoring, stress analysis, and chronic disease detection underpins the increasing preference for this sample type over traditional blood tests.

Significant advancements in multiplex testing capabilities are streamlining the diagnostic process, enabling the simultaneous detection of multiple biomarkers from a single saliva sample. Applications in fields such as occupational health, sports medicine, and oncology are further bolstering the market's prospects.

Regionally, North America dominated in 2024 with a revenue share of 48.71%, driven by an increase in infectious disease cases and advancements in testing technology. In Europe, the market benefits from a robust healthcare infrastructure and rising regional players introducing innovative solutions. Meanwhile, the Asia Pacific region is witnessing the fastest growth, driven by increasing adoption of non-invasive testing methods.

Major market players included in this report are:
• Thermo Fisher Scientific, Inc.
• Neogen Corporation
• Abbott
• Sarstedt AG & Co.KG
• Autogen, Inc.
• Oasis Diagnostics
• Porex
• Salimetrics, LLC
• Takara Bio, Inc.
• Arcis Bio
• Orasure Technologies
• Nusantics Group
• Mark Microbiotech
• Bio Farma
• Salignostics

The detailed segments and sub-segments of the market are explained below:

By Site of Collection:
• Parotid Gland Collection
• Submandibular/Sublingual Gland Collection
• Others

By Application:
• Disease Diagnostics
• Forensic Applications
• Research

By End-Use:
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Dentistry

By Region:
• North America
U.S.
Canada
Mexico
• Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
• Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
• Latin America
Brazil
Argentina
• Middle East & Africa
Saudi Arabia
South Africa
UAE
Kuwait

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecasts for 10 years (2022–2032).
• Annualized revenues and regional-level analysis for each market segment.
• Competitive landscape analysis with company profiles of major players.
• Strategic insights on emerging market trends and opportunities.